Streetbeat News

Analyst Ratings

BALY

Wells Fargo analyst Daniel Politzer has downgraded Ballys (NYSE:BALY) from Equal-Weight to Underweight while maintaining the price target at $10.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:12 pm

ACHC

Stephens & Co. analyst Scott Fidel has upgraded Acadia Healthcare Co (NASDAQ:ACHC) from Equal-Weight to Overweight and set a price target of $92.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:12 pm

NCLH

Wells Fargo analyst Daniel Politzer has downgraded Norwegian Cruise Line (NCLH) from Overweight to Equal-Weight while maintaining the price target at $18.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:11 pm

CCL

Wells Fargo analyst Daniel Politzer has upgraded Carnival Corporation (NYSE:CCL) from Equal-Weight to Overweight while maintaining the price target at $22.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:09 pm

LDOS

Barclays analyst David Strauss has upgraded Leidos Holdings (NYSE:LDOS) from Equal-Weight to Overweight, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:03 pm

RVMD

B of A Securities analyst Alec Stranahan has upgraded Revolution Medicines (NASDAQ:RVMD) from Neutral to Buy and set a price target of $34.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:02 pm

PYCR

Analysts have provided mixed ratings for Paycor HCM (NASDAQ:PYCR) with a consensus 12-month price target of $25.86, down from $26.20. Recent actions include downgrades and maintaining ratings, reflecting a cautious outlook. Paycor HCM offers payroll and HCM solutions and has shown revenue growth but faces profitability and efficiency challenges. Analysts' ratings are crucial for investors, as they are based on future earnings predictions and company risk assessments.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 1:01 pm

DNB

Over the past quarter, 5 analysts have provided diverse opinions on Dun & Bradstreet Hldgs (NYSE:DNB), with recent ratings showing 1 bullish and 2 neutral stances. The average 12-month price target is $14.26, with a high of $18.00 and a low of $10.30, marking an increase from the previous average of $13.67. Analysts from Raymond James, Truist Securities, Goldman Sachs, JP Morgan, and Needham have made various adjustments to their ratings and price targets. Dun & Bradstreet Hldgs is a provider of business decisioning data and analytics, with a lower market capitalization compared to industry averages, a revenue growth rate of 5.79%, a net margin of 0.75%, an ROE of 0.13%, an ROA of 0.05%, and a debt-to-equity ratio of 1.08.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 1:00 pm

REXR

Analysts have provided mixed evaluations for Rexford Industrial Realty (NYSE:REXR) over the last three months, with recent ratings showing a shift towards a more neutral stance. The average 12-month price target is now $55.4, a slight decrease from the previous $56.33. Rexford Industrial Realty, a REIT focusing on industrial properties in Southern California, has shown strong revenue growth and net margin but below-average ROE and ROA. The company's financial health appears stable with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 1:00 pm

ELAN

Analysts have recently updated their ratings and price targets for Elanco Animal Health (NYSE:ELAN), with a positive shift in the average 12-month price target to $15.14, up 14.7% from $13.20. The company's financials show a revenue growth of 4.09% but lag behind industry peers, and it faces challenges with a high debt-to-equity ratio of 0.96 and negative net margin and ROE. The stock's performance will be influenced by these analyst ratings and financial indicators.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 1:00 pm